Overview

The Kompas Medical Service Inc. team is composed of professionals with a network of international experts, providing integrated services with the highest professional standards to ensure optimal commercial value of the product pipeline of pharma and biotech companies.

Senior Partners

Dan Chiche MD, MBA, has a successful 20 year career history in the top tier pharmaceutical companies (Glaxo and Bristol-Myers Squibb) as an executive in Clinical Research and Medical Affairs. He is a Medical Doctor with additional training in biostatistics (Master) and business administration. He has been involved in key clinical development of compounds in various therapeutic areas, including infectious diseases, HIV, hepatitis, influenza, rheumatoid arthritis, hypertension, diabetes, COPD, asthma and is fully familiarized with clinical research standards: ICH, FDA and EMEA. During his 20 years with major pharmaceuticals, he has worked with business colleagues in order to maximize product properties, using medical communication tools, developing medical concepts and effective KOL networks. As an executive manager, he has been directly involved in the optimization of human resources and processes to deliver, on schedule, high quality outputs in clinical research and medical affairs. In 2007, Dan founded Kompas Medical Services Inc., a company providing services to Biotechs, Pharmas, and other institutions. Dan is a member of the board of director of Thallion pharmaceuticals Inc. (TSX: TLN) a publicly traded biotechnology company based in Montreal, Quebec, Canada.

Kazimerz Babinski. Pharmacist, neuroscientist and company executive with over 20 years of experience in research and development in the Life Sciences sector. As founding CEO of a start-up in drug discovery, he succeeded in raising venture capital funding, establishing strategic partnerships, and in-licensing new technologies. After a successful merger transaction that led to a major series A financing round, he became vice president of the merged entity, where he started up the operations and headed the drug development activities. His following appointment was CEO of the Center of Excellence in Personalized Medicine, a public/private organization dedicated to research and commercialization. Most recently he joined a start-up company in specializing in cellular genotyping. His expertise spans all stages of early and late preclinical development, including target validation, drug screening, lead optimization, proof-of-concept studies and non-GLP/GLP safety/tox profiling. As senior manager, his know-how also extends to strategic planning and operations, team building and leadership, IP management, due diligence, investor relations, financing and business development. He is inventor and author on several patents and scientific publications.